Clinical trial
An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives
NCT00761332 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives
- Lead sponsor
- Eli Lilly and Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- December 31, 2010
- Enrollment
- 650 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.